Cite

HARVARD Citation

    Takeuchi, A. et al. (2021). Successful treatment with ABL tyrosine kinase inhibitor for patients with acute myeloid leukemia with BCR-ABL1. Leukemia research reports. p. . [Online]. 
  
Back to record